2.43
Ac Immune Sa stock is traded at $2.43, with a volume of 356.47K.
It is up +3.85% in the last 24 hours and up +15.44% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$2.34
Open:
$2.3
24h Volume:
356.47K
Relative Volume:
2.72
Market Cap:
$244.00M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-3.4249
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
+17.39%
1M Performance:
+15.44%
6M Performance:
-10.99%
1Y Performance:
-31.16%
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ACIU
Ac Immune Sa
|
2.43 | 232.39M | 0 | -60.14M | -68.17M | -0.7095 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-31-24 | Initiated | BTIG Research | Buy |
Feb-01-19 | Downgrade | UBS | Buy → Neutral |
Jan-04-19 | Initiated | UBS | Buy |
Apr-05-18 | Initiated | H.C. Wainwright | Buy |
Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
Oct-18-16 | Initiated | Credit Suisse | Outperform |
Oct-18-16 | Initiated | Jefferies | Buy |
Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Is AC Immune SA stock a growth or value playFree Consultation - jammulinksnews.com
Published on: 2025-07-23 19:50:12 - jammulinksnews.com
What drives AC Immune SA stock priceConsistent triple-digit returns - Autocar Professional
What analysts say about AC Immune SA stockUnprecedented growth rates - Autocar Professional
AC Immune SA Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
Is AC Immune SA a good long term investmentConsistently profitable trades - jammulinksnews.com
AC Immune patent discloses new NLRP3 inflammasome inhibitors - BioWorld MedTech
How AC Immune SA stock performs during market volatilityRisk Managed Trading Strategy - Newser
Why AC Immune SA stock attracts strong analyst attentionBig Return Stock Tips - Newser
What makes AC Immune SA stock price move sharplyFree Access to Community - Newser
Encoding an entire mAb against TDP-43 into AAV to treat neurodegenerative diseases - BioWorld MedTech
AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks
Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune SA Announces Executive Changes - MarketScreener
AC Immune SA Announces Leadership Changes in Development Team - TipRanks
AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st
Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World
Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World
Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World
June 2025 Penny Stocks With Promising Potential - simplywall.st
Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World
Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com
Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World
Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st
TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient
Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):